Skip to content

SAMSARA BIOCAPITAL, LLC

Follow

13F filer, CIK 1744967, PALO ALTO, CA

SAMSARA BIOCAPITAL, LLC reported $1,051,599,250 across 27 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 87.87% of the portfolio.

Accepted , ingested 13F-HR 0001744967-26-000014

Period
2026-09-30
Reported value
$1.05B
Holdings
27
Top 10 weight
87.87%
New
4
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
PMVPnew+7,240,000$12.1M
OBXnew+837,173$11.5M
ALMSadded+890,590$6.58M
NGNEadded+150,000$4.17M
VTVTadded+56,234$1.73M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
SEPNreduced-82,675-$3.24M
GOSSexited-7,222,559-$1.19M
AQSTreduced-65,633-$304K
UPBreduced-53,356-$281K
XFORreduced-47,864-$139K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001744967-26-000014, largest first. % of portfolio is the value over $1,051,599,250, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
SRRKSCHOLAR ROCK HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,612,896 shares; 2025Q1: 5,612,896 shares; 2025Q2: 5,612,896 shares; 2025Q3: 5,612,896 shares; 2025Q4: 6,897,652 shares; 2026Q1: 6,897,652 shares; 2026Q2: 6,897,652 shares; 2026Q3: 6,897,652 shares 6,897,652$333M31.69%0Timeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,074,916 shares; 2025Q1: 5,674,916 shares; 2025Q2: 5,674,916 shares; 2025Q3: 6,263,151 shares; 2025Q4: 5,871,018 shares; 2026Q1: 5,871,018 shares; 2026Q2: 5,871,018 shares; 2026Q3: 5,871,018 shares 5,871,018$148M14.03%0Timeline
SEPNSEPTERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,768,520 shares; 2025Q1: 3,149,128 shares; 2025Q2: 3,149,128 shares; 2025Q3: 3,149,128 shares; 2025Q4: 3,149,128 shares; 2026Q1: 3,149,128 shares; 2026Q2: 3,149,128 shares; 2026Q3: 3,066,453 shares 3,066,453$120M11.41%-82,675Timeline
ALMRALAMAR BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,480,310 shares; 2026Q3: 2,480,310 shares 2,480,310$84.5M8.04%0Timeline
SGPSPYGLASS PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,109,953 shares; 2026Q2: 2,109,953 shares; 2026Q3: 2,109,953 shares 2,109,953$54.9M5.22%0Timeline
ALMSALUMIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,266,498 shares; 2025Q1: 3,266,498 shares; 2025Q2: 4,801,370 shares; 2025Q3: 4,801,370 shares; 2025Q4: 5,756,984 shares; 2026Q1: 6,345,219 shares; 2026Q2: 6,345,219 shares; 2026Q3: 7,235,809 shares 7,235,809$53.5M5.08%+890,590Timeline
NGNENEUROGENE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,717,127 shares; 2025Q1: 1,717,127 shares; 2025Q2: 1,717,127 shares; 2025Q3: 1,717,127 shares; 2025Q4: 1,717,127 shares; 2026Q1: 1,717,127 shares; 2026Q2: 1,717,127 shares; 2026Q3: 1,867,127 shares 1,867,127$51.9M4.94%+150,000Timeline
KLRSKALARIS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 11,448,081 shares; 2025Q2: 11,448,081 shares; 2025Q3: 11,448,081 shares; 2025Q4: 12,948,081 shares; 2026Q1: 12,948,081 shares; 2026Q2: 12,881,175 shares; 2026Q3: 12,881,175 shares 12,881,175$37.2M3.54%0Timeline
IVAINVENTIVA SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 5,194,805 shares; 2026Q1: 5,194,805 shares; 2026Q2: 6,314,805 shares; 2026Q3: 6,314,805 shares 6,314,805$23.3M2.22%0Timeline
PBLSPARABILIS MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 556,044 shares; 2026Q3: 556,044 shares 556,044$18M1.71%0Timeline
STROSUTRO BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 204,503 shares; 2026Q1: 1,062,872 shares; 2026Q2: 1,062,872 shares; 2026Q3: 1,062,872 shares 1,062,872$17.1M1.63%0Timeline
PMVPPMV PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 7,240,000 shares 7,240,000$12.1M1.15%newTimeline
OBXOBSIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 837,173 shares 837,173$11.5M1.09%newTimeline
AQSTAQUESTIVE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 2,500,000 shares; 2025Q4: 2,500,000 shares; 2026Q1: 2,500,000 shares; 2026Q2: 2,500,000 shares; 2026Q3: 2,434,367 shares 2,434,367$11.3M1.07%-65,633Timeline
VTVTVTV THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 206,784 shares; 2025Q1: 206,784 shares; 2025Q2: 206,784 shares; 2025Q3: 374,461 shares; 2025Q4: 298,496 shares; 2026Q1: 298,496 shares; 2026Q2: 298,496 shares; 2026Q3: 354,730 shares 354,730$10.9M1.04%+56,234Timeline
JBIOJADE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 531,163 shares; 2025Q3: 531,163 shares; 2025Q4: 968,798 shares; 2026Q1: 968,798 shares; 2026Q2: 736,237 shares; 2026Q3: 736,237 shares 736,237$10.3M0.98%0Timeline
NKTXNKARTA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,768,035 shares; 2025Q1: 3,768,035 shares; 2025Q2: 3,768,035 shares; 2025Q3: 3,768,035 shares; 2025Q4: 3,507,666 shares; 2026Q1: 3,507,666 shares; 2026Q2: 3,507,666 shares; 2026Q3: 3,507,666 shares 3,507,666$9.19M0.87%0Timeline
RANIRANI THERAPEUTICS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 8,500,000 shares; 2026Q1: 8,500,000 shares; 2026Q2: 10,369,159 shares; 2026Q3: 10,369,159 shares 10,369,159$8.2M0.78%0Timeline
ARTVARTIVA BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 291,666 shares; 2025Q1: 291,666 shares; 2025Q2: 291,666 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 954,861 shares; 2026Q3: 954,861 shares 954,861$6.8M0.65%0Timeline
AGMBAGOMAB THERAPEUTICS NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 600,000 shares; 2026Q2: 600,000 shares; 2026Q3: 594,749 shares 594,749$6.6M0.63%-5,251Timeline
ELOXELOXX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 400,000 shares; 2026Q3: 400,000 shares 400,000$6.12M0.58%0Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 850,000 shares; 2025Q1: 425,000 shares; 2025Q2: not reported; 2025Q3: 75,442 shares; 2025Q4: 75,442 shares; 2026Q1: 56,581 shares; 2026Q2: 55,095 shares; 2026Q3: 55,095 shares 55,095$5.46M0.52%0Timeline
CHRSCOHERUS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,428,571 shares; 2026Q2: 3,428,571 shares; 2026Q3: 3,383,565 shares 3,383,565$4.09M0.39%-45,006Timeline
XFORX4 PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,960,000 shares; 2026Q1: 1,832,566 shares; 2026Q2: 1,395,587 shares; 2026Q3: 1,347,723 shares 1,347,723$3.91M0.37%-47,864Timeline
UPBUPSTREAM BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,217,146 shares; 2025Q1: 2,067,146 shares; 2025Q2: 1,443,231 shares; 2025Q3: 962,154 shares; 2025Q4: 736,047 shares; 2026Q1: 736,047 shares; 2026Q2: 353,717 shares; 2026Q3: 300,361 shares 300,361$1.58M0.15%-53,356Timeline
TCGXTCGX ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 100,000 shares 100,000$1.25M0.12%newTimeline
GOSSGOSSAMER BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 87,956 shares 87,956$1.04M0.1%newTimeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
GOSSGOSSAMER BIO INC7,222,559$1.19Mshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001744967-26-000014 base2026-11-16